Immuno-Oncology and Cell Therapy

Serving the IO and Cell Therapy Community

Lead Webcast

Immuno-Oncology Debate on Solving Cancer’s Top Challenges

The 2024 IO360º debate focuses on cell therapy versus bispecific engagers, which therapy will be most successful in solid tumors, and which therapy will lead to the next step change.

Understanding TGF-Beta's Role in Tumor Growth and Targeting to the Right Tumor

Developing a Neoantigen-Directed Cancer Vaccine with Gritstone Bio

Breakthroughs in Systemic Immunotherapy using a Novel Drug Delivery System

Taking Lessons from the Last Decade of IO to Develop the Next Wave of Therapeutics

Videos & Webcasts

A Taste of the IO360º Experience

Crafting and Telling Your Leadership Story

The Personal Impact of a Cancer Immunotherapy Trial

Using AI to Accelerate the Next Generation of Oncology Immunotherapies

Dr Kristen Hege Looks Back at Lessons Learned from a Career in CAR-T Therapy

Targeting Clonal Tumor Neoantigens and their Key Role in Immune Response

Fireside Chat: The Future of CAR-T, Cell Therapy, T-Cell Engagers and Synthetic Immunity

Nobel Laureate Keynote: Bioorthogonal and Click Chemistries’ Impact on Advancing Immuno-Oncology

The Patient Story: The Incredible Immunotherapy That Gave Him Back His Life

Biotech CEO Leadership on the Business and Science of Cell and Gene Therapy

Regulatory Opportunities to Accelerate the Development of Cell Therapies

Priming the Immune System to Provoke Checkpoints and Maintain the Immunotherapy Momentum

How MD Anderson is Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy

How Synthetic Biology & Synthetic Circuits In Cell Therapy Can Advance the Field

Dr Arie Belldegrun Discusses His Vision for Treating Cancer

Serving the IO and Cell Therapy Community

Lead Webcast

Immuno-Oncology Debate on Solving Cancer’s Top Challenges

Featured Videos & Webcasts

Understanding TGF-Beta's Role in Tumor Growth and Targeting to the Right Tumor

Developing a Neoantigen-Directed Cancer Vaccine with Gritstone Bio

Breakthroughs in Systemic Immunotherapy using a Novel Drug Delivery System

Taking Lessons from the Last Decade of IO to Develop the Next Wave of Therapeutics

More Related Content

Videos & Webcasts

A Taste of the IO360º Experience

Crafting and Telling Your Leadership Story

The Personal Impact of a Cancer Immunotherapy Trial

Using AI to Accelerate the Next Generation of Oncology Immunotherapies

Dr Kristen Hege Looks Back at Lessons Learned from a Career in CAR-T Therapy

Targeting Clonal Tumor Neoantigens and their Key Role in Immune Response

Fireside Chat: The Future of CAR-T, Cell Therapy, T-Cell Engagers and Synthetic Immunity

Nobel Laureate Keynote: Bioorthogonal and Click Chemistries’ Impact on Advancing Immuno-Oncology

The Patient Story: The Incredible Immunotherapy That Gave Him Back His Life

Biotech CEO Leadership on the Business and Science of Cell and Gene Therapy

Regulatory Opportunities to Accelerate the Development of Cell Therapies

Priming the Immune System to Provoke Checkpoints and Maintain the Immunotherapy Momentum

How MD Anderson is Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy

How Synthetic Biology & Synthetic Circuits In Cell Therapy Can Advance the Field

Dr Arie Belldegrun Discusses His Vision for Treating Cancer

Subscribe for More Information

Search By Type:

Search By Category:

Search Within Date Range:

Serving the IO and Cell Therapy Community

Lead Webcast

Immuno-Oncology Debate on Solving Cancer’s Top Challenges

Featured Videos & Webcasts

Understanding TGF-Beta's Role in Tumor Growth and Targeting to the Right Tumor

Developing a Neoantigen-Directed Cancer Vaccine with Gritstone Bio

Breakthroughs in Systemic Immunotherapy using a Novel Drug Delivery System

Taking Lessons from the Last Decade of IO to Develop the Next Wave of Therapeutics

More Related Content

Videos & Webcasts

A Taste of the IO360º Experience

Crafting and Telling Your Leadership Story

The Personal Impact of a Cancer Immunotherapy Trial

Using AI to Accelerate the Next Generation of Oncology Immunotherapies

Dr Kristen Hege Looks Back at Lessons Learned from a Career in CAR-T Therapy

Targeting Clonal Tumor Neoantigens and their Key Role in Immune Response

Fireside Chat: The Future of CAR-T, Cell Therapy, T-Cell Engagers and Synthetic Immunity

Nobel Laureate Keynote: Bioorthogonal and Click Chemistries’ Impact on Advancing Immuno-Oncology

The Patient Story: The Incredible Immunotherapy That Gave Him Back His Life

Biotech CEO Leadership on the Business and Science of Cell and Gene Therapy

Regulatory Opportunities to Accelerate the Development of Cell Therapies

Priming the Immune System to Provoke Checkpoints and Maintain the Immunotherapy Momentum

How MD Anderson is Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy

How Synthetic Biology & Synthetic Circuits In Cell Therapy Can Advance the Field

Dr Arie Belldegrun Discusses His Vision for Treating Cancer

Subscribe for More Information